BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.8 EUR
0.72%
Updated:
May 2, 2024
P/OCF
Price to OCF
Price to OCF
-12.7
Current
-40.3
Median
12.7
Industry
Higher
than median
Lower
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=-12.7
Market Cap
/
61.2m
Operating Cash Flow
-4.8m
All Countries
| Market Cap | P/OCF | ||||
|---|---|---|---|---|---|
| DE |
|
BRAIN Biotech AG
XETRA:BNN
|
61.2m EUR | -12.7 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.1T JPY | 15.2 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
77.1B USD | 21.9 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
64.3B USD | 26.7 | |
| CH |
|
Sika AG
SIX:SIKA
|
42.2B CHF | 25.7 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
36.6B CHF | 26.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
279.8B CNY | 10.4 | |
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
33.7B USD | 17.6 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.9T INR | 45.2 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
30.7B USD | 13.6 | |
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
28.1B EUR | 22.2 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
